Solvency II’s 2025 SFCR season has delivered a structural capital build across Europe’s largest insurance groups: nine of the ten largest EU groups recorded a higher SCR ratio in 2025 than in 2024, lifting the aggregate SCR ratio to 228% from 218% as eligible own funds rose 5% to EUR 405.6 billion while the solvency capital requirement grew by just 1% to EUR 178.2 billion. The picture across the UK’s Solvency UK framework diverges sharply: the UK aggregate ratio across 213 groups fell from 192% to 187%, while the EU aggregate rose from 217% to 226% — opening a 41-percentage-point gap that reflects deliberate strategic choices by large UK composites rather than capital distress.
EOF Outrunning SCR: What the EU Aggregate Capital Data Shows
The aggregate data published by Solvency II Wire Data covering the ten largest EU groups shows that eligible own funds grew 5% to EUR 405.6 billion against a 1% increase in aggregate SCR to EUR 178.2 billion — a gap that compounds structural surplus across the sector. Individual group highlights: Allianz reported a Solvency II ratio of 218% in 2025, up 9 percentage points from 209% in 2024, and simultaneously proposed a dividend of EUR 17.10 per share (up 11%) alongside a EUR 2.5 billion share buyback. Munich Re reached 300% including transitional measures, up from 289%. NN Group delivered the most striking individual move: its Solvency II ratio rose to 220% — the group’s highest since 2016 — driven by positive market impacts and strong operating capital generation exceeding capital flows to shareholders.
Generali’s ratio rose to 219% from 210%, maintaining the pattern of southern European composites strengthening capital positions ahead of the January 2027 regulatory transition. The single exception in the top-10 EU cohort is Crédit Agricole Assurances, which fell slightly — still well above standard comfort thresholds but worth monitoring as the bancassurance model faces margin pressure from the same rate environment that boosted pure-play P&C and reinsurance capital positions. The direction of travel — validated by Generali’s strong early-2026 results — is one of deliberate capital accumulation ahead of a regulatory uplift that will change the denominator rather than the numerator.
The UK Divergence: Aviva and L&G’s Ratio Falls Signal Strategy, Not Stress
The UK aggregate ratio decline to 187% is almost entirely explained by two deliberate capital deployments, not operational deterioration. Aviva’s Solvency II shareholder cover ratio fell to 180% from 203% in 2024, driven by the Direct Line acquisition (completed in mid-2025), which consumed capital upfront before integration synergies flow into capital generation. Aviva has guided significant capital synergies by end-2026, implying a roughly 10pp ratio recovery that would restore the group toward its historical range. Legal & General’s ratio fell 29 percentage points to 203% from 232%, driven by £1,247 million in dividends and a £503 million share buyback — a deliberate capital return strategy reflecting confidence in the Matching Adjustment model’s cash generativity, not capital weakness.
The EU-UK divergence is a regime design story, not a credit quality one. Solvency II’s calibration benefits from spread compression and rate dynamics in ways that the UK’s Matching Adjustment-centric framework does not amplify in the same direction. As EIOPA locked in Solvency II supervisory guidelines for January 2027 implementation, the EU framework’s future trajectory is toward a wider EOF-SCR gap — meaning EU groups that are already at 218–228% are building structural headroom ahead of a regulatory event that will expand it further. UK groups, by contrast, are deliberately using existing surplus for M&A and distributions before the PRA’s own matching adjustment reforms fully play out.
Directive 2025/2 and the 5-20pp Uplift That Reshapes 2027 Capital Planning
The forward-looking significance of the 2025 SFCR season is the baseline it establishes before Directive (EU) 2025/2 — the Solvency II omnibus review — takes effect in January 2027. Fitch projects the reform could lift EU group ratios by 5-7 percentage points on average, with some groups seeing uplifts of up to 20 percentage points, driven by changes to the risk margin calculation, long-term guarantee measures, and macroprudential proportionality tools. For a sector where the current aggregate stands at 228%, an additional 5–7pp pushes headline ratios into new territory — a level at which the capital management conversation shifts decisively from “maintaining surplus” to “deploying surplus efficiently.”
For insurers and reinsurers in the below-average ratio band — still respectable but below the sector leaders — the January 2027 uplift creates a one-time window to recalibrate M&A parameters, shareholder return programs, and alternative asset allocation without triggering rating agency concern. Groups that anticipate the uplift in their 2026 planning cycle — rather than reacting to it in H1 2027 — will be better positioned to move on acquisition targets or alternative asset build-outs before peer valuations adjust to reflect the same improved capital headroom. The 2025 SFCR data is therefore not a backward-looking scorecard: it is the baseline from which every European insurance CFO is now pricing the 2027 capital event.
